
Mexmet 25 Tablet ER
Marketer
UTH Healthcare
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Mexmet 25 Tablet ER
Cardiobeta 25 Extended-Release tablets are classified as beta-adrenergic blocking agents. This medication treats hypertension (high blood pressure), angina pectoris (chest pain associated with heart disease), and cardiac arrhythmias (irregular heartbeats). It's also used to prevent migraine headaches, recurrent heart attacks, and stroke. Cardiobeta 25 ER may be administered alone or in conjunction with other drugs; dosage and frequency are determined by the condition being treated and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefit may take several weeks, and continuous use may be necessary. Discontinuing treatment, even if feeling well, can worsen underlying conditions. Common side effects, typically mild and transient, include fatigue, headache, depression, diarrhea, skin rash, bradycardia (slow heart rate), dizziness, and nausea. Some individuals may experience shortness of breath or hypotension (low blood pressure). To minimize adverse effects, your physician will likely initiate treatment with a low dose, gradually increasing it as needed. Report persistent or bothersome side effects to your doctor. Prior to commencing therapy, inform your physician of any liver disorders. This medication may be unsuitable for patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating women should seek medical advice before use. Always discuss suitability with your doctor, and undergo regular blood pressure monitoring to assess treatment effectiveness. Alcohol consumption should be limited due to potential exacerbation of side effects.
Uses of Mexmet 25 Tablet ER
Managing angina pectoris (chest pain from heart disease) | Addressing cardiac arrhythmias | Heart attack prophylaxis | Hypertension (high blood pressure) management | Migraine prevention
Major Benefits of Mexmet 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or break it. Mexmet 25 ER Tablets can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and meat while taking Mexmet 25 ER Tablets.
Common Side effects of Mexmet 25 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Mexmet 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Mexmet 25 Tablet ER whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistent timing is recommended. High-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meat, should be avoided when taking Mexmet 25 Tablet ER.
How Mexmet 25 Tablet ER works:
Extended-release Mexmet 25mg tablets are a cardioselective beta-adrenergic blocking agent, reducing heart rate and improving the heart's pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mexmet 25 Tablet ER and alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Mexmet 25mg tablets might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Mexmet 25mg tablets are likely safe for breastfeeding mothers. Available evidence from human studies indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Mexmet 25 mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Mexmet 25 Extended-Release tablets pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Mexmet 25 Extended-Release tablets. Dosage modification of Mexmet 25 Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Mexmet 25 Tablet ER :
Should you forget a dose of Mexmet 25 Tablet ER, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Mexmet 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Type of Treatment | Heart |
